The parenteral and enteral nutrition market in the Dominican Republic is witnessing accelerating demand driven by a sustained increase in hospital admissions, coupled with a rising prevalence of chronic Non-Communicable Diseases (NCDs) and obesity. As more individuals require inpatient and post-operative care, Intensive Care Unit (ICU) stays, and long-term management of conditions such as diabetes, hypertension, and obesity‐related complications, the need for specialized enteral and parenteral nutrition support is becoming more prominent. This trend is underpinned by shifting demographics, healthcare infrastructure expansion, and growing public health recognition of diet‐related health burdens, which together position clinical nutrition as an essential component of both acute and chronic care strategies.
Access Full Report @ https://www.databridgemarketresearch.com/reports/dominican-republic-parenteral-and-enteral-nutrition-market
Data Bridge market research analyzes that the Dominican Republic Parenteral and Enteral Nutrition Market is expected to reach USD 118,054.43 million by 2032 from USD 68,716.74 thousand in 2024 growing at a CAGR of 7.1% in the forecast period of 2024 to 2032.
Key Findings of the Study
REGIONAL MARKET EXPANSION IS IMPROVING PRODUCT AVAILABILITY AND VARIETY IN THE DOMINICAN REPUBLIC
Regional market expansion has materially improved the availability and diversity of parenteral and enteral nutrition products in the Dominican Republic, thereby functioning as a key market driver. Expansion of the country’s life-sciences manufacturing base, greater participation of multinational suppliers in free-trade zones, concerted public investment in hospital infrastructure and procurement, and strengthened partnerships with multilaterals and regional trade partners have collectively increased the range of formulations, delivery systems, and sterile supplies available to hospitals and home-care providers. These developments reduce lead times, broaden product choice for clinicians, and lower barriers for the introduction of specialised clinical-nutrition lines, reinforcing both acute-care and long-term nutrition management capabilities across the health system.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2025 to 2032
|
|
Base Year
|
2024
|
|
Historic Years
|
2023 (Customizable to 2018-2022)
|
|
Quantitative Units
|
Revenue in USD thousand
|
|
Segments Covered
|
By Product Type (Eternal Nutrition (EN) and Parenteral Nutrition (PN), By Age Group (Adult, Geriatric, and Pediatric), By Care Type (Acute Care, Post Acute, Preoperative Care, Urgent Care, General Care and Others), By Distribution Channel (Direct Trader, Retail Sales and Others)
|
|
Countries Covered
|
DOMINICAN REPUBLIC
|
|
Market Players Covered
|
Fresenius Kabi AG (Germany), Nestlé Health Science (Switzerland), Abbott Laboratories (Abbott) (U.S.), B. Braun SE (Germany), Baxter International Inc. (U.S.), Bayer AG (Germany), Nutricia (Netherlands), Grifols, S.A. (Spain), Mead Johnson Nutrition (U.S.), Cardinal Health, Inc. (U.S.), Carbery Group (Ireland), Macrotech (China), Botanic Supplements, LLC (U.S.), Grupo Hospifar (Dominican Republic), B&D Nutritional Ingredients (U.S.), AAK AB (Sweden), Otsuka Holdings Co., Ltd. (Japan), Balaxi Pharmaceuticals Limited (India) and among others.
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.
|
Segment Analysis
The Dominican Republic Parenteral and Enteral Nutrition Market is categorized into four notable segments which are product type, age group, care type, and Distribution Channel.
- On the basis of product type, the market is segmented into Eternal Nutrition (EN) and Parenteral Nutrition (PN).
In 2025, the Eternal Nutrition (EN) segment is expected to dominate the market
In 2025, the Eternal Nutrition (EN) segment is expected to dominate the market with a market share of 64.61%. due to its lower risk of complications, cost-effectiveness, and increased preference for gastrointestinal-based feeding methods in both clinical and homecare settings.
- On the basis of age group, the market is segmented into adult, geriatric, and pediatric.
In 2024 the adult segment is expected to dominate the market
In 2024 the adult segment is expected to dominate the market with a market share of 58.13%. due to the higher prevalence of chronic diseases, increased surgical interventions, and a growing number of hospital admissions among the adult population, driving the demand for both enteral and parenteral nutrition support.
- On the basis of care type, the market is segmented into acute care, post acute, preoperative care, urgent care, general care, and others.
In 2025, the Acute Care segment is expected to dominate the market
In 2025, the Acute Care segment is expected to dominate the market with a market share of 39.08%. due to the rising number of critical illness cases, trauma incidents, and intensive care admissions requiring immediate and closely monitored nutritional support.
- On the basis of distribution channel, the market is segmented into direct trader, retail sales, and others.
In 2025, the Direct Trader segment is expected to dominate the market
In 2025, the Direct Trader segment is expected to dominate the market with a market share of 61.20%. due to strong procurement relationships with hospitals and healthcare facilities, better pricing structures for bulk purchases, and streamlined supply chain operations that ensure timely delivery of clinical nutrition products.
Major Players
Fresenius Kabi AG (Germany), Nestlé Health Science (Switzerland), Abbott Laboratories (Abbott) (U.S.), B. Braun SE (Germany), Baxter International Inc. (U.S.), Bayer AG (Germany), Nutricia (Netherlands), Grifols, S.A. (Spain), Mead Johnson Nutrition (U.S.), Cardinal Health, Inc. (U.S.), Carbery Group (Ireland), Macrotech (China), Botanic Supplements, LLC (U.S.), Grupo Hospifar (Dominican Republic), B&D Nutritional Ingredients (U.S.), AAK AB (Sweden), Otsuka Holdings Co., Ltd. (Japan), Balaxi Pharmaceuticals Limited (India) and among others.
Market Developments
- In February 2024, Fresenius Kabi advanced its collaboration with the European Society for Intensive Care Medicine (ESICM) to enhance research and medical training in intensive care, underpinning educational initiatives and professional development. This strategic partnership strengthened Fresenius Kabi's position in clinical nutrition by fostering innovation and expertise, ultimately driving better patient outcomes and reinforcing the company's leadership in the healthcare sector.
- In April 2023, Fresenius Medical Care received the CIO 100 Award for its innovative tool predicting intradialytic hypotension in hemodialysis patients. This success underscored Fresenius Kabi's commitment to technological advancements, enhancing their clinical nutrition solutions by integrating predictive analytics to improve patient outcomes.
- In March 2022, Fresenius Kabi acquired a majority stake in mAbxience and purchased Ivenix to drive strategic growth in Biopharmaceuticals and MedTech. This strengthened Fresenius Kabi's Clinical Nutrition division by enhancing its product offerings and expanding its technological capabilities, ultimately improving patient care and market reach.
- In October 2023, Nestlé announced a collaboration with Amwell to enhance patient outcomes through digital nutrition solutions. Their first initiative, the Advanced Surgical Nutrition Automated Care Program, combined Amwell’s virtual technology with Nestlé’s Impact ADVANCED RECOVERY drink to support surgical recovery. This collaboration benefited Nestlé by strengthening its position in the Home Enteral Nutrition (HEN) market, showcasing their commitment to integrating nutrition and technology to improve clinical outcomes.
As per Data Bridge Market Research analysis:
For more detailed information about the Dominican Republic Parenteral and Enteral Nutrition Market report, click here – https://www.databridgemarketresearch.com/reports/dominican-republic-parenteral-and-enteral-nutrition-market
